RPTXRepare Therapeutics Inc.

RPTX Stock Price, Valuation & Chart | Repare Therapeutics Inc.

Compare

$2.650+0.00 (+0.00%)

At close · 28 Jan 2026, 09:00 pm

Sector: Healthcare Industry: Biotechnology RPTX intrinsic value RPTX calculated fair value vs price

Overview Financials Dividends Ratios

RPTX Historical price chart

RPTX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization114.24M

PE Ratio-1.56

EPS-1.7

Trading Volume1.17M

Today's High/Low2.65/2.65

Dividend Yield0.00

52 Week High/Low2.66/0.89

Shares Outstanding43.11M

RPTX Financial Statement

RPTX Analyst ratings

RPTX Analysis & performance metrics

RPTX Company profile

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United…

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA…

RPTX Management team

Name

Position

Sandra Alves

Senior Vice President & Chief Accounting Officer

Agnel Sfeir Ph.D.

Co-Founder

Steve Forte CPACEO

President, Chief Financial Officer, Chief Executive Officer & Director

Daniel Belanger

Executive Vice President of Human Resources

Daniel Durocher Ph.D.

Co-Founder

Michael Zinda Ph.D.

Executive Vice President & Chief Scientific Officer

Frank Sicheri Ph.D.

Co-Founder

Joseph P. O'Connell M.D.

Executive Vice President of Clinical Development and Medical Affairs

Name

Position

Sandra Alves

Senior Vice President & Chief Accounting Officer

Agnel Sfeir Ph.D.

Co-Founder

Steve Forte CPACEO

President, Chief Financial Officer, Chief Executive Officer & Director

Daniel Belanger

Executive Vice President of Human Resources

Daniel Durocher Ph.D.

Co-Founder

Michael Zinda Ph.D.

Executive Vice President & Chief Scientific Officer

Frank Sicheri Ph.D.

Co-Founder

Joseph P. O'Connell M.D.

Executive Vice President of Clinical Development and Medical Affairs

Management Team

Sandra Alves

Senior Vice President & Chief Accounting Officer

Agnel Sfeir Ph.D.

Co-Founder

Steve Forte CPACEO

President, Chief Financial Officer, Chief Executive Officer & Director

Daniel Belanger

Executive Vice President of Human Resources

Daniel Durocher Ph.D.

Co-Founder

Michael Zinda Ph.D.

Executive Vice President & Chief Scientific Officer

Frank Sicheri Ph.D.

Co-Founder

Joseph P. O'Connell M.D.

Executive Vice President of Clinical Development and Medical Affairs

Management

Sandra Alves

Senior Vice President & Chief Accounting Officer

Agnel Sfeir Ph.D.

Co-Founder

Steve Forte CPACEO

President, Chief Financial Officer, Chief Executive Officer & Director

Daniel Belanger

Executive Vice President of Human Resources

Daniel Durocher Ph.D.

Co-Founder

Michael Zinda Ph.D.

Executive Vice President & Chief Scientific Officer

Frank Sicheri Ph.D.

Co-Founder

Joseph P. O'Connell M.D.

Executive Vice President of Clinical Development and Medical Affairs

Total 8 executives

RPTX Frequently asked questions

What is Repare Therapeutics Inc. (RPTX) Stock Price?

Current stock price of Repare Therapeutics Inc. (RPTX) stock is $2.650. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Repare Therapeutics Inc. (RPTX) stock is 1.17M.

Last updated at 28 Jan 2026, 09:00 pm.

Why is the Repare Therapeutics Inc. (RPTX) stock price going up or down today?

The stock price of Repare Therapeutics Inc. (RPTX) can change with earnings, company news, and overall market sentiment. Repare Therapeutics Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Repare Therapeutics Inc. stock expensive at its current price?

Whether Repare Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RPTX on this page is -1.56. EPS on this page is -1.70. Compare those figures with peers and growth expectations before deciding if the current Repare Therapeutics Inc. price is justified.

How has the stock price of Repare Therapeutics Inc. (RPTX) performed historically?

Historical performance for Repare Therapeutics Inc. (RPTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RPTX reacted to past earnings and market events.

Should I buy Repare Therapeutics Inc. (RPTX) stock, at this price?

Buying Repare Therapeutics Inc. (RPTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.